UHSNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31

UNIVERSAL HEALTH SERVICES INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$182.29−2.81 (-1.52%)

Close on Oct 19, 2026

Market cap: $10.92B
P/E (TTM): 7.4
Dividend yield: 0.44%

UNIVERSAL HEALTH SERVICES INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Revenue	17,365	15,828	14,282	13,399	12,642	11,559	11,378	10,772	10,410	9,766	9,043	8,205	7,368	6,961	6,760	4,900	–	–
Operating Expenses	15,371	14,146	13,107	12,396	11,279	10,201	10,162	9,597	9,130	8,485	7,784	7,142	6,352	6,019	5,863	4,394	4,682	4,612
Operating Income	1,994	1,682	1,175	1,004	1,363	1,358	1,216	1,175	1,280	1,281	1,259	1,063	1,015	943	897	506	521	410
Interest Expense	156	186	207	127	84	106	163	155	145	125	113	134	146	179	201	78	46	53
Other Non-Operating Income	134	2.23	-28	-10	14	0.01	13	14	0	0	–	–	–	–	–	–	–	–
Asset Impairment Charges	–	0	0	58	14	0	0	49	0	0	0	0	0	0	0	–	–	–
Gain (Loss) on Investments	93	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	–	–	–	7.84	3.11	27	0.45	1.99	1.35	21
Pretax Income	1,972	1,498	940	866	1,293	1,252	1,066	1,035	1,135	1,156	1,146	930	869	764	696	428	475	357
Income Tax Expense	461	335	221	209	306	299	239	237	364	409	395	325	315	275	247	152	170	123
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	751	605	554	489	449	276	304	234
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	–	–	2.51	14	6.75	7.63	–	6.44
Net Income incl. Noncontrolling Interests	1,511	1,163	719	657	988	953	828	798	771	747	751	605	554	489	449	276	304	240
Minority Interest in Earnings	22	21	1.51	-19	-3.96	8.84	13	18	19	45	70	60	43	46	51	46	44	41
Net Income	1,489	1,142	718	676	992	944	815	780	752	702	681	545	511	443	398	230	260	199
Net Income to Common	1,489	1,142	717	675	990	–	–	–	–	–	–	–	–	–	-0.52	-0.92	-1.15	–
EPS (Basic)(per share)	23.42	17.16	10.35	9.23	11.99	11.06	9.16	8.35	7.86	7.22	6.89	5.52	5.21	4.57	4.09	2.37	2.65	1.96
EPS (Diluted)(per share)	23.10	16.82	10.23	9.14	11.82	10.99	9.13	8.31	7.81	7.14	6.76	5.42	5.14	4.53	4.04	2.34	2.64	1.96
Shares Outstanding (Basic, Weighted)(shares)	64	67	69	73	83	85	89	93	96	97	99	99	98	97	97	97	98	101
Shares Outstanding (Diluted, Weighted)(shares)	64	68	70	74	84	86	89	94	96	98	101	101	99	98	99	98	98	101
Dividend per Share(per share)	0.80	0.80	0.80	0.80	0.80	–	0.60	0.40	–	–	–	0.30	0.20	0.60	0.20	0.20	0.17	–
EBITDA	2,613	2,267	1,743	1,585	1,896	1,869	1,706	1,628	1,728	1,698	1,658	1,439	1,353	1,251	1,193	730	725	606
Net Interest Income	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 11.4%
Net margin: 8.4%
Return on equity, FY2025: 21.4%

Financial strength

Current ratio: 1.12
Debt to equity: 0.65
Debt to assets: 30.4%
Cash to current liabilities: 4.2%

Valuation

P/E ratio: 7.4
Price to sales: 0.60
Price to book: 1.45
Dividend yield: 0.44%